Prevention of iatrogenic acute narrow-angle glaucoma

Area of Science:

• Ophthalmology
• Medical Diagnostics

Background:

• Glaucoma is a leading cause of irreversible blindness.
• Pharmacologic mydriasis, or pupil dilation, can pose risks in certain patients.
• Understanding these risks is crucial for patient safety.

Purpose of the Study:

• To review the pathophysiology of glaucoma.
• To discuss the risks associated with pharmacologic pupillary dilation.
• To describe a novel screening test for identifying at-risk patients.

Main Methods:

• Literature review of glaucoma pathophysiology.
• Analysis of risks associated with mydriatic agents.
• Description of a transillumination screening test.

Main Results:

• Pharmacologic mydriasis can exacerbate certain glaucoma conditions.
• A simple transillumination test can identify patients susceptible to mydriasis-induced complications.
• This screening method aids in preemptive risk assessment.

Conclusions:

• Awareness of glaucoma pathophysiology is key to managing mydriasis risks.
• The transillumination screening test offers a practical approach to patient safety.
• Implementing this test can help prevent adverse events in at-risk glaucoma patients.